Redeye comments on yesterday’s news about Apple launching Eye tracking.
Redeye provides an update following SenzaGen’s Q1 report.
Redeye updates its estimates following Sozap’s Q1 report.
Redeye provides an update on Thunderful Group following its Q1 2024 report, showing weak numbers as ...
Arctic Blue Beverages har publicerat bolagets delårsrapport för det första kvartalet år 2024.
Obducat AB (publ) (”Obducat” eller ”Bolaget”) levererade ett rekordår 2023, där Bolaget uppvisar en ...
As announced already in February, capacity utilization and turnover in Q1 were weighed down by the p...
Redeye is encouraged to see that Impact Coatings has received another order for an IC2000-system for...
I samband med Eisais rapport annonserades att företaget räknar med en försäljning av Leqembi på JPY5...
Redeye comments on Raketech’s Q1-results which were in line with the preliminary outcome that was an...
Redeye comments on Thunderful Group’s Q1'24 report, which was weak and came in line with preliminary...
Aspo’s CMD elaborated on major investment plans as both ESL and Telko will expand their operations a...
Redeye comments on Sozap’s Q1 results, which revealed sales roughly in line with expectations, while...
Sales -3%, EBIT +15%, order book -2% v.s. ABGSCe EBIT margin strengthened to 4.
Redeye provides an research update following Starbreeze Q1-report; Some positive comments from manag...
Redeye updates on EG7 post Q1-results which were weaker than expected owing to soft performance in t...
Redeye is optimistic about the new data from lymphoma patients treated with subcutaneous as well as ...
Redye provides a research update following the Q1 2024 report from Precise Biometrics.
Mixed markets; US strong but Germany weaker '24e-'26e EBIT down 4-3% on lowered Germany estimates Sh...
- Solid start in Q1 - Higher sales commissions weigh down on EBIT in '25e-'26e - Fair value revised ...